Cadiz Inc. (NASDAQ:CDZI) recorded a trading volume of 241056 shares, below its 5-day volume average of 313620 shares. The stock kicked off the session at $9.24 and later approached $9.53 with a change of 3.14%.Cadiz Inc. Earnings Surprise
Revenue had a distance of -81.82% from the previous quarter, with the company recording $20000 in revenue.
The shares of Cadiz Inc. (NASDAQ:CDZI) have struggled and recovered 11.72% ever since it recorded its 52 week low. During the course of 5 days, the stock price volatility has remained at 5.84%, increasing the time frame to a month, the volatility recorded was 3.32%. The price of their shares still hasn’t been successful in staying above its 20 day-moving average, staying at a distance of -2.81% and while its 50-day moving average is around -4.89%. In a look at the previous five trading session CDZI stock has returned -3.15% and sank -14.61% when compared to its 200-day moving average that is $10.42. Cadiz Inc. (CDZI) will look to overcome its -31.44% fall that it witnessed in the past year.
As the normal trading session ended, the stock of Clovis Oncology, Inc. (NASDAQ:CLVS), fetched in a $-0.98 retreat to $25.3. The session began with the stock price at $26.13, hitting a high of $26.25 before down again. For the week, analysts seem to be okay with their neutral with the consensus call staying at 2. Clovis Oncology, Inc. gets 3 buy analyst recommendations while 3 recommend a hold and 0 rated it as a sell. The shares of the company tumbled -61.22% from its high $65.24, with their overall market value now roughly $1.34 billion.Clovis Oncology, Inc. (CLVS) Consensus Price Target
The mean recommendation of CLVS on Reuter’s scale remained unchanged from 2 to 2 within 30 days. This figure implies that the majority of analysts rate it as a buy. The price target for Clovis Oncology, Inc. (NASDAQ:CLVS) is now around $32.5 a share, implying the stock has what it takes to grow by 28.46%. The recent trading session also indicated the stock needs to add 58.1% more meet analysts’ high consensus price target.Clovis Oncology, Inc. (NASDAQ:CLVS) Intraday Trading
The current trading volume of the company was 1263217 shares during the last session. That compares with the recent average volume of 1367560 shares. By the end of the regular trading session, the price volatility over a 1-week span was 4.31 % while over a month it stood at 6.39%. The stock price of CLVS dropped to $24.94 during the day and at a certain time in 12 months it traded as low as $11.5. It has made a 120% recovery since its 52-week low point and has returned 40.87% year-to-date. [T3]